Search results for "rating"

showing 10 items of 2021 documents

Virtual reality exposure and imaginal exposure in the treatment of fear of flying: a pilot study

2013

Fear of flying (FF) is an impairing psychological disorder that is extremely common in developed countries. The most effective treatment for this particular type of phobia is exposure therapy. However, there are few studies comparing imaginal exposure (IE) and virtual reality (VR) exposure for the treatment of FF. The present study compared the effectiveness of these two approaches using two manualized interventions based on the exposure technique. Patients with FF ( N = 15) were randomly assigned to either VR ( n = 7) or IE therapy ( n = 8), consisting of a total of eight sessions: two assessment sessions (pre-treatment and after the real flight) and six exposure therapy sessions, which w…

AdultMalemedicine.medical_specialtyAdolescentAircraftmedicine.medical_treatmentExposure therapyPsychological interventionImplosive TherapyPilot ProjectsVirtual realityVirtual realityVirtual Reality Exposure TherapyFear of flyingArts and Humanities (miscellaneous)Fear of flyingImaginal exposureDevelopmental and Educational PsychologymedicinePresenceEffective treatmentHumansPsychiatryAgedPsychiatric Status Rating ScalesVirtual Reality Exposure TherapyMiddle Agedmedicine.diseaseClinical PsychologyPhobic DisordersImaginal capabilityPhysical therapyAnxietyImplosive TherapyFemalemedicine.symptomPsychology
researchProduct

Risperidone Versus Haloperidol and Amitriptyline in the Treatment of Patients With a Combined Psychotic and Depressive Syndrome

1998

In a multicenter, double-blind, parallel group trial, the efficacy of risperidone (RIS) was compared with a combination of haloperidol and amitriptyline (HAL/AMI) over 6 weeks in patients with coexisting psychotic and depressive symptoms with either a schizoaffective disorder, depressive type, a major depression with psychotic features, or a nonresidual schizophrenia with major depressive symptoms according to DSM-III-R criteria. A total of 123 patients (62 RIS; 61 HAL/AMI) were included; the mean daily dosage at endpoint was 6.9 mg RIS versus 9 mg HAL combined with 180 mg AMI. Efficacy results for those 98 patients (47 RIS; 51 HAL/AMI) who completed at least 3 weeks of double-blind treatme…

AdultMalemedicine.medical_specialtyAdolescentAmitriptylineSchizoaffective disorderAntidepressive Agents Tricycliclaw.inventionDouble-Blind MethodExtrapyramidal symptomsRandomized controlled triallawInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmitriptylinePsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderRisperidoneMiddle AgedRisperidonemedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaHaloperidolFemalemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory

2007

Background: Depressive symptoms are a major complaint reported by cancer patients. Somatic and affective symptoms can contribute to depression. Patients and methods: We investigated the prevalence of somatic and affective depressive symptoms with the Beck Depression Inventory (BDI) in 213 hospitalized cancer patients prior to the start of chemotherapy. Results: Seventeen of 213 patients (8%) were screened positive for major depression; 40 (19%) had mild to moderate depressive symptoms. The corresponding figures for somatic and affective symptoms were 33.3% and 2.8% in the patients with major depression and 23.0% and 8.0% in those with mild to moderate depressive symptoms. Female patients, p…

AdultMalemedicine.medical_specialtyAdolescentComorbidityRisk AssessmentStatistics NonparametricHospitals UniversityAge DistributionQuality of lifeGermanyNeoplasmsSickness Impact ProfileSurveys and QuestionnairesInternal medicineAdaptation PsychologicalInterview PsychologicalPrevalencemedicineHumansSex DistributionPsychiatryDepression (differential diagnoses)AgedProbabilityPsychiatric Status Rating ScalesDepressive Disorderbusiness.industryCase-control studyBeck Depression InventoryCancerHematologyMiddle Agedmedicine.diseaseComorbidityChemotherapy regimenCausalityOncologyCase-Control StudiesQuality of LifeMajor depressive disorderFemalebusinessStress PsychologicalFollow-Up StudiesAnnals of Oncology
researchProduct

Texture analysis in susceptibility-weighted imaging may be useful to differentiate acute from chronic multiple sclerosis lesions.

2020

To evaluate the diagnostic performance of texture analysis (TA) applied on non-contrast-enhanced susceptibility-weighted imaging (SWI) to differentiate acute (enhancing) from chronic (non-enhancing) multiple sclerosis (MS) lesions. We analyzed 175 lesions from 58 patients with relapsing-remitting MS imaged on a 3.0 T MRI scanner and applied TA on T2-w and SWI images to extract texture features. We evaluated the presence or absence of lesion enhancement on T1-w post-contrast images and performed a computational statistical analysis to assess if there was any significant correlation between the texture features and the presence of lesion activity. ROC curves and leave-one-out cross-validation…

AdultMalemedicine.medical_specialtyAdolescentContrast Media030218 nuclear medicine & medical imagingLesion03 medical and health sciencesYoung Adult0302 clinical medicineMultiple Sclerosis Relapsing-RemittingImage Processing Computer-AssistedMedicineHumansMultiple sclerosiRadiology Nuclear Medicine and imagingDiagnosis Computer-AssistedLeast-Squares AnalysisNeuroradiologyAgedRetrospective Studiesmedicine.diagnostic_testReceiver operating characteristicbusiness.industryMultiple sclerosisUltrasoundReproducibility of ResultsMagnetic resonance imagingGeneral MedicineMiddle Agedmedicine.diseaseMagnetic Resonance ImagingRegressionLogistic modelsContrast agentROC Curve030220 oncology & carcinogenesisArea Under CurveSusceptibility weighted imagingAcute DiseaseChronic DiseaseRegression AnalysisFemaleRadiologymedicine.symptomSettore MED/36 - Diagnostica Per Immagini E RadioterapiabusinessEuropean radiology
researchProduct

Blood pressure for outcome prediction and risk stratification in acute pulmonary embolism.

2015

Abstract Introduction Risk stratification of patients with acute pulmonary embolism (PE) is crucial in deciding appropriate therapy management. Blood pressure (BP) is rapidly available and a reliable parameter. We aimed to investigate BP for short-term outcome in acute PE. Materials and methods Data of 182 patients with acute PE were analyzed retrospectively. Logistic regression models were calculated to investigate associations between BP and in-hospital-death as well as myocardial necrosis. Moreover, receiver operating characteristic (ROC) curves and cutoff values for systolic and diastolic BPs predicting in-hospital death and myocardial necrosis were computed. Results A total of 182 pati…

AdultMalemedicine.medical_specialtyAdolescentDiastoleBlood PressureRisk AssessmentNecrosisYoung AdultInternal medicinemedicineHumansHospital MortalityAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testReceiver operating characteristicbusiness.industryVentilation/perfusion scanMyocardiumArea under the curveBlood Pressure DeterminationGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisConfidence intervalSurgeryPulmonary embolismBlood pressureLogistic ModelsROC CurveAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismThe American journal of emergency medicine
researchProduct

Dose-Related Effects of Amisulpride on Five Dimensions of Psychopathology in Patients With Acute Exacerbation of Schizophrenia

2002

The present analysis investigated symptom-specific dose-response relationships of the atypical antipsychotic amisulpride (AMI) in schizophrenic patients. The effects of different AMI doses on five different symptom dimensions of the Brief Psychiatric Rating Scale (BPRS) were analyzed. Results on global efficacy and safety parameters have been previously published. Four AMI doses (100 mg/day [AMI100], 400 mg/day [AMI400], 800 mg/day [AMI800], 1200 mg/day) were compared with 16 mg haloperidol (HAL16) in a multicenter, double-blind, randomized, parallel-group, 4-week trial. A total of 319 patients with acute exacerbation of schizophrenia (DSM-III-R) were included. AMI100 was compared with the …

AdultMalemedicine.medical_specialtyAdolescentExacerbationmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticInternal medicineBrief Psychiatric Rating ScalemedicineHaloperidolHumansPharmacology (medical)AmisulpridePsychiatryAntipsychoticPsychiatric Status Rating ScalesDose-Response Relationship DrugDopamine antagonistMiddle AgedPsychiatry and Mental healthTreatment OutcomeSchizophreniaHaloperidolAnxietyFemaleSchizophrenic PsychologyAmisulprideSulpiridemedicine.symptomPsychologyAntipsychotic Agentsmedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a r…

2017

Purpose To assess the diagnostic performance of mean apparent diffusion coefficient (mADC) in differentiating benign from malignant bone spine tumors, using histology as a reference standard. Conventional magnetic resonance imaging (MRI) sequences have good reliability in evaluating spinal bone tumors, although some features of benign and malignant cancers may overlap, making the differential diagnosis challenging. Materials and Methods In all, 116 patients (62 males, 54 females; mean age 59.5 ± 14.1) with biopsy-proven spinal bone tumors were studied. Field strength/sequences: 1.5T MR system; T1-weighted turbo spin-echo (repetition time / echo time [TR/TE], 500/13 msec; number of excitatio…

AdultMalemedicine.medical_specialtyAdolescentIntraclass correlationGadoliniumchemistry.chemical_elementSensitivity and Specificity030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciencesYoung Adult0302 clinical medicineImage Interpretation Computer-AssistedmedicineEffective diffusion coefficientHumansRadiology Nuclear Medicine and imagingStage (cooking)AgedRetrospective StudiesAged 80 and overSpinal Neoplasmsmedicine.diagnostic_testReceiver operating characteristicbusiness.industryEcho-Planar ImagingReproducibility of ResultsMagnetic resonance imagingMiddle AgedReference StandardsConfidence intervalSpineDiffusion Magnetic Resonance Imagingchemistry030220 oncology & carcinogenesisFemaleRadiologyNuclear medicinebusinessDiffusion MRIJournal of magnetic resonance imaging : JMRI
researchProduct

An interdisciplinary study towards a multiaxial classification of male sexual dysfunction

1991

The classification of male sexual dysfunction (SD) was investigated in a multidisciplinary study involving a sample of 25 outpatients whose phenomenology, course and biologic comorbidity is described. All 25 patients were suffering from arousal disorders; 9 men complained of lack of desire and 9 of orgasm disorders. For the vast majority (19/25), the arousal disorder preceded the other sexual dysfunctions. Eleven patients suffered from a psychopathological disorder according to DSM-III or DSM-III-R (Axis I and II), with general anxiety, major depression and obsessive-compulsive personality being the most common disorders. Only 6 patients were free of any organic disorder or pathological lab…

AdultMalemedicine.medical_specialtyAdolescentLibidomedia_common.quotation_subjectArousalDiagnosis DifferentialErectile DysfunctionRisk FactorsmedicineHumansPersonalityOrgasmPsychiatryPathologicalmedia_commonPatient Care TeamPsychiatric Status Rating ScalesMiddle Agedmedicine.diseasePsychophysiologic DisordersComorbidityPsychiatry and Mental healthSexual dysfunctionAnxietymedicine.symptomPsychologyAnxiety disorderPsychopathologyActa Psychiatrica Scandinavica
researchProduct

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depressi…

2003

OBJECTIVE Current clinical knowledge holds that antidepressants have a delayed onset of efficacy. However, the delayed onset hypothesis has been questioned recently by survival analytical approaches. We aimed to test whether early improvement under antidepressant treatment is a clinically useful predictor of later stable response and remission. METHOD We analyzed data from a randomized double-blind controlled trial with mirtazapine and paroxetine in patients with major depression (DSM-IV). Improvement was defined as a 17-item Hamilton Rating Scale for Depression (HAM-D-17) score reduction of > or = 20%. Stable response was defined as > or = 50% HAM-D-17 score reduction at week 4 and week 6,…

AdultMalemedicine.medical_specialtyAdolescentMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatrySurvival analysisDepression (differential diagnoses)AgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedPrognosisParoxetineSurvival AnalysisClinical trialPsychiatry and Mental healthParoxetineTreatment OutcomeAntidepressantDrug Therapy CombinationFemalePsychologySelective Serotonin Reuptake Inhibitorsmedicine.drug
researchProduct

Screening for Hypochondriasis With the Illness Attitude Scales

2010

The Illness Attitude Scales (IAS; Kellner, 1986, 1987) may prove highly useful for the screening of hypochondriasis. We expected the IAS subscales to be equally as effective as the 7-item short version of the Whiteley Index (Whiteley-7; Fink et al., 1999), which has previously been shown to be useful in screening for somatoform disorders. We investigated participants of a German population (n = 1,575) and 61 patients with the Diagnostic and Statistical Manual of Mental Disorders (4th ed. [DSM-IV]; American Psychiatric Association, 1994) diagnosis of hypochondriasis. The Bodily Preoccupations (BP) subscale showed high sensitivity (.92) and specificity (.90) as well as demonstrating convergen…

AdultMalemedicine.medical_specialtyAdolescentPersonality InventoryPsychometricsValidation testHealth Toxicology and MutagenesisTest validitySensitivity and SpecificityYoung AdultSex FactorsArts and Humanities (miscellaneous)German populationGermanymedicineHumansPsychiatryAgedAged 80 and overPsychiatric Status Rating ScalesAge FactorsDiscriminant validityReproducibility of ResultsMiddle AgedHypochondriasisClinical PsychologyConvergent validityPsychiatric status rating scalesEducational StatusFemalePersonality Assessment InventoryPsychologyJournal of Personality Assessment
researchProduct